Three bottle sizes, one mercury cream, and a new sunscreen filter
The Simple micellar recall now covers 200, 400, and 730 ml. Plus: what a bemotrizinol approval does and does not change.
Good morning. Today's issue is built from the wire: two official safety actions you can act on, one regulatory change that will take a while to reach a shelf near you, and a review that quietly argues for boring routines.
As always, the grade sits on the exact claim, never on the brand.
The U.K. Office for Product Safety and Standards widened the recall from the 730 ml bottle to listed batches of the 200 ml and 400 ml sizes over possible microbial contamination. Check the batch code against the official annex; bottles not on the list are not recalled.
FDA laboratory testing found high mercury levels in a skin-lightening cream sold online, undisclosed on the label. Stop using it, and bring the label to a clinician if you have. This is a finding about one named product, not a verdict on every pigment product.
The FDA's final order permits bemotrizinol at concentrations up to 6% in over-the-counter sunscreens. Finished products still depend on manufacturers and compliant formulas, so this changes what can be sold, not what is on shelves today.
FDA reports 16,398 active facility registrations and 1,298,361 product listings under MoCRA as of June 30. Listing is a traceability requirement. It is not approval, and a listed product is not a vetted product.
A 2026 narrative review looked at the nonmedicated vehicle groups in controlled trials for acne, melasma, rosacea, and more, and found meaningful improvement from basics alone. It is not a meta-analysis, and one author disclosed industry fees.
Verdict: reasonable, with a Grade A on petrolatum as an occlusive. It is a standard recommendation for dry or irritated skin applied to everyone; the file names who should skip it and how to slug selectively.
Match the provider's training and the device's authorization to the exact procedure and goal, then ask for realistic outcomes, alternatives, downtime, pigment risk, and a complication plan.
Reply to this email with a question or a correction. Corrections are sent to the same inbox, dated, and appear on the file itself.
The Daily Considered
Make sense of the next skincare headline.
A short briefing on skincare news, research, and procedures. What matters, why it matters, and the sources behind it.
Keep reading. Follow new stories in your feed reader, or explore a sample briefing. Email subscriptions are not available yet.